Eligibility for radioiodine therapy depends on several factors, including the type and stage of thyroid cancer, previous treatments, and the overall health of the patient. Typically, it is recommended for patients who have undergone thyroidectomy and have residual thyroid tissue or metastases that absorb iodine.
